Focused Ultrasound for Stimulant Use Disorder
Part of Mental health clinical trials.
This trial tests a non-invasive brain treatment called focused ultrasound for people with stimulant use disorder (like methamphetamine or cocaine). It aims to help reduce cravings and improve recovery by gently stimulating a brain area involved in addiction.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 60 years old.
- You have been diagnosed with a stimulant use disorder (like methamphetamine or cocaine) by a doctor.
- You are currently in a substance use treatment program (inpatient or intensive outpatient).
- You have stopped using stimulants and other illegal drugs, confirmed by a urine test.
- You are able to lie still for 2–3 hours and can safely have an MRI scan (no metal implants, no allergies to MRI dye).
- You have no serious heart, kidney, bleeding, or psychiatric conditions that would make the procedure unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a low-intensity focused ultrasound treatment for people with severe opioid or amphetamine use disorder. The ultrasound targets a part of the brain linked to addiction, and the goal is to see if it is safe and helpful.
This trial uses focused ultrasound (sound waves aimed at a specific part of the brain) to help people who have severe opioid addiction that hasn't gotten better with other treatments. It may help reduce cravings and support recovery.
This trial studies Exablate, a non-surgical brain treatment that aims to change activity in a specific brain area involved in cravings and substance use. It is meant for people in structured opioid or substance use treatment who are currently abstaining from opioids and other illicit drugs.
This test uses a safe, non-invasive brain stimulation method called TMS (transcranial magnetic stimulation) to see if it can help people with stimulant use disorder reduce their cravings and stay sober. You would need to be in an addiction treatment program and have been clean for at least 2 weeks to join.
This trial tests whether a single dose of psilocybin (PEX010) combined with therapy can help people stop using methamphetamine or other stimulants. It focuses on safety and early signs of effectiveness.
This study tests if focused ultrasound can help reduce alcohol cravings by stimulating a specific part of the brain. Participants will receive ultrasound treatments and undergo an MRI to see how the brain responds.
Hear when a new Psychostimulant Use Disorder(PUD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.